Previous Article | Next Article ![]()
Journal of Virology, July 2000, p. 6614-6621, Vol. 74, No. 14
St. Vincent's Institute of Medical Research,
Fitzroy, Victoria, Australia
Received 13 January 2000/Accepted 17 April 2000
Retrovirus entry into cells follows receptor binding by the
surface-exposed envelope glycoprotein (Env) subunit (SU), which triggers the membrane fusion activity of the transmembrane (TM) protein. TM protein fragments expressed in the absence of SU adopt helical hairpin structures comprising a central coiled coil, a region
of chain reversal containing a disulfide-bonded loop, and a C-terminal
segment that packs onto the exterior of the coiled coil in an
antiparallel manner. Here we used in vitro mutagenesis to test the
functional role of structural elements observed in a model helical
hairpin, gp21 of human T-lymphotropic virus type 1. Membrane fusion
activity requires the stabilization of the N and C termini of the
central coiled coil by a hydrophobic N cap and a small hydrophobic
core, respectively. A conserved Gly-Gly hinge motif preceding the
disulfide-bonded loop, a salt bridge that stabilizes the chain reversal
region, and interactions between the C-terminal segment and the coiled
coil are also critical for fusion activity. Our data support a model
whereby the chain reversal region transmits a conformational signal
from receptor-bound SU to induce the fusion-activated helical hairpin
conformation of the TM protein.
Retrovirus infection is initiated by
the viral envelope (Env) glycoproteins that comprise a receptor-binding
subunit (SU) associated with a transmembrane (TM) protein. Envelope
glycoproteins are synthesized as precursors and are processed in the
Golgi apparatus to yield a mature functional SU-TM protein complex. The
mature Env proteins are incorporated into budding virions at the plasma membrane. Retrovirus entry into cells follows SU-mediated attachment to
cellular receptors and TM protein-mediated fusion between the viral
envelope and target cellular membrane. Cell surface-localized Env
proteins can also mediate cell-to-cell retrovirus transmission by
fusion between infected cells and target cells.
X-ray crystallography and nuclear magnetic resonance studies have
revealed structural similarities in TM protein fragments derived from
diverse retroviruses (7, 11, 22, 28, 33, 48, 51),
orthomyxoviruses (6, 13, 42, 52), a filovirus (Ebola virus)
(34, 50), and a paramyxovirus (simian virus 5)
(4). Retroviral and filoviral TM protein structures are long
rods comprising an N-terminal central triple-stranded coiled coil, a
disulfide-bonded loop associated with a chain reversal at the base of
the rod, and a structurally diverse C-terminal ectodomain segment that
packs against the exterior of the central coiled coil in an
antiparallel manner. These structures, referred to as helical hairpins
(12, 45), imply that the hydrophobic N-terminal fusion
peptide and C-terminal TM sequence are juxtaposed at one end of the rod
in a fusion-activated or postfusion conformation.
Retroviral TM protein hairpins resemble the fusion-activated
conformation of the influenza virus TM protein, HA2, suggesting a
common mechanism for membrane fusion. The conformational changes accompanying HA2 fusion activation, which are induced by low endosomal pH, involve a helical extension at the N terminus of the central coiled
coil which would relocate the fusion peptide from the HA2 core to the
tip of the rod, allowing insertion into the target cellular membrane.
The envelope-proximal portion of the coiled coil refolds, resulting in
reversal of the chain direction, packing of the C-terminal segment on
the outside of the coiled coil, and placement of the TM sequence close
to the N terminus (6, 14). These conformational changes are
thought to draw together and destabilize the viral envelope or infected
cell membranes and target cell membranes, inducing membrane fusion. The
fusion potential of HA2 is thought to result from the low-pH-induced
transition from the metastable, prefusogenic conformation to the most
stable, fusion-activated conformation (9, 13, 14). Recent
biochemical studies with human immunodeficiency virus type 1 (HIV-1)
and avian leukosis and sarcoma virus Env indicate that binding between
the viral SU and cellular receptor(s) leads to conformational changes in the SU-TM complex that correlate with increased TM protein hydrophobicity and membrane fusion activity (15, 26, 27).
We reported recently the 2.5-Å-resolution crystal structure of the
human T-lymphotropic virus type 1 (HTLV-1) gp21 helical hairpin
(28) (Fig. 1A). The structure
of gp21 encompassed residues Met-338 to Thr-425 and was solved as part
of a chimera with Escherichia coli maltose-binding protein
(MBP-gp21). Here we describe the functional consequences of mutating
residues within the key structural elements of gp21 that are conserved
in retroviral and filoviral TM hairpins. We identified functional roles
for (i) a hydrophobic structure that caps the N terminus of the central
coiled coil (Fig. 1B); (ii) the region of chain reversal comprising a
small hydrophobic core containing Phe-386, a conserved Gly-Gly motif preceding the disulfide-bonded loop, the conserved salt bridge formed
between Glu-398 (found within the disulfide-bonded loop) and Arg-380 at
the base of the coiled coil, and a conserved solvent-exposed phenylalanine residue (Phe-402) located C terminal to the
disulfide-bonded loop (Fig. 1D); and (iii) sites of interaction between
the C-terminal ectodomain segment and the coiled coil (Fig. 1E).
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Functional Implications of the Human T-Lymphotropic Virus Type 1 Transmembrane Glycoprotein Helical Hairpin Structure

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

View larger version (59K):
[in a new window]
FIG. 1.
Location of mutated residues in the three-dimensional
structure of gp21. (A) Ribbon diagram of the gp21(338-425) trimer. The
coiled-coil-forming helices are colored magenta, the disulfide-bonded
loop is green, the C-terminal helices are cyan, and the rest of the
chain is grey. The side chains of residues mutated in this study are
also shown; the mutated residues in the helix cap region are colored
yellow, the mutated residues in the chain reversal region are colored
red, and the mutated residues in the C-terminal helix region are
colored blue. The atomic radii of C
atoms of glycine residues have
been enlarged for clarity. (B) Close-up view of the helix cap region,
colored as in panel A. The side chain of Ser-339 and the first heptad
repeat residue, Leu-346, are also shown colored in grey. (C)
Superimposition of the N-cap regions of gp21 and HA2. The structures
have been superimposed using 45 N-terminal residues in the coiled-coil
helices. HA2 is colored cyan (residues 33 to 43 of the N-terminal
region of the coiled coil) and blue (residues 171 to 177 of the
C-terminal segment), and gp21 residues are colored magenta (residues
338 to 345). The structures are viewed down the threefold axis of the
coiled coil. (D) Close-up view of the chain reversal region, colored as
in panel A. The side chains of some residues interacting with the
mutated residues are also shown colored in grey. (E) Close-up view of
the C-terminal helix region, colored as in panel A. The side chains
of some residues interacting with the mutated residues are also
shown colored in grey. The figure was prepared with the programs
BOBSCRIPT (20) and RASTER3D (35).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell lines and viruses. 293T and HeLa cells were transfected by the Fugene procedure (Boehringer GmbH, Mannheim, Germany) and maintained in Dulbecco's modification of minimal essential medium with 10% fetal calf serum (complete medium). The recombinant vaccinia virus vTF7.3, which drives expression of bacteriophage T7 polymerase, was obtained from T. M. Fuerst and B. Moss (36).
Expression vector construction.
The cytomegalovirus
promoter-driven HTLV-1 Env expression vector pCMV-ENV was a gift of
M.-C. Dokhélar (41). This vector was modified to
pCELT.1, which expresses HTLV-1 Env, C-terminally tagged with the
monoclonal antibody (MAb) C8 epitope (1, 10). Mutations were
introduced into a KpnI-NsiI fragment
(env nucleotides 939 to 1388) by PCR mutagenesis. The
sequences of Env mutants were confirmed by the ABI Prism BigDye
terminator system (Applied Biosystems). pMBPL
/gp21(338-425) drives
the expression of MBP-gp21 in E. coli (10, 28).
Mutations were introduced into the gp21 domain by PCR. The firefly
luciferase open reading frame was cloned into the
NcoI-StuI sites of pTM.1 (obtained from B. Moss)
(36) to yield pTMluc. An HIV-1NL4.3
Env expression vector, pcgp160NL4.3, was constructed by
cloning the EcoRI-SalI fragment from pNL4.3 (obtained from M. A. Martin) (2) into the
cytomegalovirus-based vector pCDNA3 (Invitrogen).
Antibodies. MAb C8 (directed against the HIV-1 Env cytoplasmic tail) was obtained from G. Lewis (1), while MAb 46 (directed against HTLV-1 gp46) was a gift of David Tribe, The University of Melbourne, Melbourne, Victoria, Australia. Immunoglobulin G was purified from the plasma of an HTLV-1-infected individual (anti-HTLV) using protein A-Sepharose (Pharmacia Biotech).
Western blotting.
Transfected 293T cells were lysed for 10 min on ice in phosphate-buffered saline containing 1% Triton X-100,
0.02% sodium azide, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 5 µg of aprotinin ml
1, 5 µg of leupeptin
ml
1, and 1 mM dithiothreitol. Lysates were clarified by
centrifugation at 10,000 × g at 4°C prior to
polyacrylamide gel electrophoresis in the presence of sodium dodecyl
sulfate (SDS-PAGE) in 12% polyacrylamide gels under reducing
conditions. Proteins were transferred to nitrocellulose prior to
Western blotting with MAb C8 using the Boehringer chemiluminescence blotting substrate procedure.
Assessment of cell surface Env expression using an antibody
binding assay.
The chloramine-T procedure (24) was used
to radioiodinate anti-HTLV. The radioiodinated antibody was precleared
with 107 293T cells for 2 h on ice before its addition
to transfected 293T cells at 48 h posttransfection. The
transfected cells were incubated with 125I-anti-HTLV for
1 h on ice in phosphate-buffered saline containing 10 mg of bovine
serum albumin ml
1 with occasional gentle agitation. The
cells were then washed four times with the same buffer before counting
in a Packard Auto-Gamma counter.
Luciferase reporter assay for cell-to-cell fusion.
293T
(effector) cells were cotransfected with the pCELT.1 and
pTMluc vectors. Twenty-four hours later, HeLa target cells
were infected with vTF7.3 at a multiplicity of infection of 1 PFU per cell. At 16 h postinfection, HeLa cells were resuspended in
phosphate-buffered saline containing 50 µM EDTA, washed twice in
complete medium, and then cocultured with transfected 293T cells for a
further 6 h in the presence of 1 µg of actinomycin D
ml
1 and 40 µg of cytosine arabinoside ml
1
at 37°C. Cells were then lysed and assayed for luciferase activity using the Promega (Madison, Wis.) luciferase assay system.
Biosynthetic labeling and immunoprecipitation. Transfected 293T cells were first incubated for 30 min in cysteine- and methionine-deficient medium (ICN, Costa Mesa, Calif.) at 27 h posttransfection and then labeled with 120 µCi of [35S]cysteine (ICN) per well for 14 h. Immunoprecipitations were performed as described previously (40).
Expression and purification of MBP-gp21 chimeras.
Fusion
proteins were induced in E. coli strain BL21 (DE3/pLysS)
cells by the addition of 0.2 mM
isopropyl-
-D-thiogalactopyranoside (IPTG) and then
purified as described previously (10). MBP-gp21 chimera
oligomers were isolated by Superdex 200 (HiLoad 26/60) gel filtration
chromatography (Pharmacia Biotech) in S buffer as described previously
(10). The gel filtration calibration markers, blue dextran,
ferritin (440 kDa), catalase (232 kDa), and bovine serum albumin (67 kDa), were obtained from Pharmacia Biotech. Reducing SDS-PAGE (10%
polyacrylamide gels) revealed a single ~45-kDa band for all chimeras.
Electrospray mass spectrometry (PE Sciex API III instrument
[10]) indicated that the monomer molecular mass of
each chimera was within 5 Da of the calculated molecular mass.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Maturation of Env mutants.
The HTLV-1 Env precursor, gp62, is
cleaved in the Golgi apparatus to yield the mature SU, gp46, and the TM
protein, gp21, which remain noncovalently associated (39).
Mutant forms of gp62 were expressed in similar quantities in 293T cells
and in most cases processed to yield similar amounts of gp21
(Fig. 2A), indicating intracellular
translocation of cleavage-competent Env structures. The F402H,
F402L, F402A, and H409P mutants had reduced cleavage, indicative of
folding defects that blocked maturation.
|
75% of
that of the wild type for all but two cleavage-defective mutants, F402H and F402A (Fig. 2B). Background levels of binding to 293T cells transfected with negative control plasmids were 10% ± 2% for pTM.1 and 11% ± 4% for pcgp160NL4.3. The surface expression
levels of the cleavage-defective mutants F402L and H409P were >80% of
that of wild-type Env. These results suggest that the mutations altered the conformation of the SU-TM protein cleavage site in the absence of
major global conformational defects, as has been previously documented
for HIV-1 Env mutants (8, 18, 21, 43). By contrast, the
surface expression of F402 and F402A mutants was decreased by ~50%
and was consistent with global conformational defects that cause
retarded translocation.
The gp46-anchoring ability of gp21 mutants was compared by
immunoprecipitation of gp46 shed from [35S]Cys-labeled
293T cells. Similar levels of cell-associated (Fig. 2C) and shed (Fig.
2D) gp46 were observed for wild-type Env and for the mutants tested
(i.e., mutants that were cleaved normally but were fusion defective
[see Fig. 3]). Thus, all mutants appear to mature normally with the
exception of F402H, F402L, F402A, and H409P.
Functional role of the N-terminal helix cap.
The gp21
coiled-coil N terminus is stabilized by contacts between the C
atom
of Met-338 and the C
, C
, and C
2 atoms of the first helical
residue, Leu-340, about the threefold symmetry axis. The remainder of
the Met-338 side chain occupies a cavity associated with Gly-343 at the
N terminus of the coiled coil (Fig. 1B). This hydrophobic helix-capping
structure differs from typical N caps, where the residue immediately
preceding the N terminus of an
-helix, hydrogen, bonds with the NH
group of the third helical residue; Ser, Thr, Asn, Asp, and Cys are the
most favored N-capping residues (17). The side chain of the
first nonhelical residue of gp21, Ser-339, points into solvent without
making any helix contacts. The gp21 helix cap is an essential
functional determinant, because substitutions at either Met-338 or
Leu-340 led to decreases in fusion activity correlating inversely with the hydrophobicity of the substituting side chain (Fig.
3). These substitutions did not affect
Env maturation (Fig. 2), suggesting that the helix cap may be important
in the fusion-activated structure.
|
Functional role of the chain reversal region.
At the base of
the gp21 coiled coil, a complex substructure mediates a chain reversal
to enable the antiparallel packing of the C-terminal segment against
the exterior of the coiled coil. The substructure comprises a
310-helix (Trp-387 to Gln-389), a conserved
Gly-390-Gly-391 hinge motif, a short
-helix (Leu-392 to Ala-395),
and the disulfide-bonded loop (Cys-393 to Cys-400) (Fig. 1D).
Corresponding substructures are present in the murine leukemia virus
(MuLV)TM protein (p15E [22]) and in GP2 of Ebola virus
(34, 50) (Fig. 4). These
substructures pack roughly perpendicular to the coiled coil through
hydrophobic and polar interactions.
|
(i) A hydrophobic core at the base of the coiled coil.
A small
hydrophobic core is formed at the base of the coiled coil where Phe-386
packs with Ala-395 within the disulfide-bonded loop and with Leu-384
and Leu-385 of an adjacent monomer's central
-helix (Fig. 1D).
Whereas replacement of Phe-386 with other bulky residues (His and Ile)
was tolerated, an F386A substitution reduced fusion activity to 20% of
that of the wild type (Fig. 3). This effect is most likely due to a
decrease in protein stability resulting from the creation of a cavity
in a hydrophobic core, as has been observed in other systems
(19). Replacement of Phe-386 with Tyr decreased fusion
activity by approximately 50%, probably due to steric problems
associated with the burial of the larger and more polar side chain of
tyrosine. None of these substitutions affected Env maturation,
suggesting that the contacts mediated by Phe-386 are most critical in
the context of a fusion-activated structure. Thus, hydrophobic
interactions appear to play an important role in stabilizing both ends
of the central coiled coil in a fusion-competent gp21 structure.
Hydrophobic clusters are present at similar positions in MuLV p15E
(22) and Ebola virus GP2 (34, 50), highlighting
their general importance in stabilizing the base of the central coiled
coil of fusion-competent Env.
(ii) The conserved diglycine motif preceding the disulfide-bonded
loop.
Most retroviruses (excluding type B retroviruses and
lentiviruses of ungulates) and filoviruses contain one or more glycines immediately N terminal to the disulfide-bonded loop of the TM protein.
The gp21, p15E, and GP2 crystal structures reveal that the Gly-Gly
hinge motif precedes a short
-helix (Leu-392 to Ala-395 in gp21)
that contains the first cysteine of the disulfide bridge (Fig. 4).
Replacement of either Gly-390 or Gly-391 of gp21 with Pro, a residue
that severely limits the flexibility of protein backbones by
restricting rotation about the N-C
bond (46), led to the
complete abolition of Env fusion function (Fig. 3) without affecting
Env maturation (Fig. 2). We tested the effect of the proline mutations
on the trimerization of the MBP-gp21 chimera, which contains the gp21
helical hairpin (28). We assumed that MBP-gp21 trimerization
indicated the formation of the gp21 hairpin, whereas aggregation
indicated misfolding. MBP containing three alanines fused to its C
terminus has a monomeric structure (10). Superdex-200 gel
filtration chromatography shows that both the G390P and G391P mutations
induced aggregation of the MBP-gp21 chimera (Fig.
5). The block in fusogenicity may
therefore be due to an inability of gp21 with a Pro substitution to
fold into a helical hairpin. Because the Gly-to-Pro substitutions did not affect Env maturation, the conserved Gly-Gly motif appears to be
essential for the formation of the helical hairpin structure, perhaps
by functioning as a flexible hinge to facilitate the conversion of
prefusogenic Env to the fusion-active form.
|
(iii) The Arg-380-Glu-398 salt bridge. Glutamic acid-398 within the gp21 disulfide-bonded loop forms a salt bridge with Arg-380 or a hydrogen bond with Gln-377, located close to the base of the coiled-coil-forming sequence of an adjacent monomer. Fusion activity (Fig. 3) and MBP-gp21 trimerization (Fig. 5), but not Env maturation (Fig. 2), were abolished by an E398N substitution that precludes the electrostatic interaction with Arg-380, creating a small cavity at this site. The proteins with the more conservative substitution mutations E398Q (geometry) and E398D (charge) retained approximately 50% of wild-type fusion activity. These intermediate phenotypes may be due to the Gln side chain maintaining a hydrogen bond with Gln-377 while an Asp maintains a less favorable electrostatic contact with Arg-380. The electrostatic contact is conserved in the helical hairpin structures of MuLV p15E (Arg-542 to Glu-560) and Ebola virus GP2 (Lys-588 to Asp-607) (Fig. 4); structure-based alignments of retroviral TM protein sequences suggest that these electrostatic contacts are also likely to be important features in TM proteins of type D and avian leukosis and sarcoma retroviruses (28). Our observations suggest that these conserved salt bridges serve to stabilize or position the region of chain reversal against the base of the coiled coil in the helical hairpin.
(iv) The conserved, solvent-exposed Phe-402. Phenylalanine-402 occupies a solvent-exposed position on the C-terminal side of the disulfide-bonded loop, adjacent to the unpaired Cys-401. Mutation of Phe-402 to Leu, His, or Ala led to the abolition of Env maturation (Fig. 2). The inhibition of processing with mutants of Phe-402 suggests that it plays a structural role in gp62, implying that Phe-402 may be associated with the core of prefusogenic Env, becoming solvent exposed during the formation of the helical hairpin. Phenylalanine-402 does not, however, appear to be essential for the acquisition of the helical hairpin conformation, because the F402L mutation was tolerated in the MBP-gp21 trimer (Fig. 5).
Phenylalanine residues that are C terminal to the disulfide-bonded loop are conserved in the TM proteins of type C (e.g., MuLV) and type D retroviruses (28). The solvent-exposed Phe-564 of MuLV p15E (Fig. 4) is adjacent to the unpaired Cys-563, which forms a labile disulfide bond with SU. Proteolysis experiments have suggested that the SU sequence C312WLCL, which closely resembles the active-site sequences of thiol-disulfide exchange enzymes, is responsible for the labile disulfide bond with Cys-563 (38). Because this SU sequence is rich in hydrophobic residues, it may be a contact site for Phe-564 in the SU-TM protein interface. Similar CXXCX motifs (where X is a hydrophobic residue) are present in the SUs of HTLV-1 (C226IVCI), HTLV-2, bovine leukemia virus, and type C and type D retroviruses, providing potential docking sites for the Phe-564 homologs of these viruses. A possible mechanism for TM fusion activation may require SU-receptor binding to trigger the expulsion of Phe-402 from the core of prefusogenic SU-TM protein complex to become solvent exposed in the fusion-activated helical hairpin. It should be noted that the receptor-binding GP1 subunit of filoviruses and the SU of avian leukosis and sarcoma retroviruses do not contain thiol-disulfide exchange CXXCX motifs, which may account for the stable covalent associations between GP1-GP2 (44) and SU-TM protein complex (29) in these viruses. Nevertheless, Ile-610 of Ebola virus GP2 occupies a solvent-exposed position homologous to Phe-402 of gp21 (Fig. 4), while avian leukosis and sarcoma virus TM proteins also contain gp21 Phe-402 homologs, suggesting conserved functional roles for these hydrophobic residues.Interactions between the coiled coil and the C-terminal ectodomain
segment.
The C-terminal ectodomain segment of gp21 (Leu-403 to
Asn-421) packs into a groove on the surface of the coiled coil, burying a large complementary surface area (28). This packing is
mediated in part by the C-terminal
-helix residues, His-409,
Val-410, Ile-412, Leu-413, and Gln-414, contacting the coiled-coil
residues. The results presented in Fig. 3 indicate that polar
interactions mediated by His-409 (Fig. 1E) are not important for
fusogenicity, whereas hydrophobic interactions between Val-410 and
His-365 are essential. The C-terminal
-helical structure may also be
important, because fusion activity is abolished by the S411P mutation,
which was designed to introduce a kink into the
-helical element.
Tyrosine-374 is located on the surface of the coiled coil, making
hydrophobic contacts with Cys-401 and Leu-403 of the C-terminal segment
and a hydrogen bond with Arg-379 of an adjacent monomer's
coiled-coil-forming sequence (Fig. 1D). These contacts are also
essential for Env fusion competence, as mutation of Tyr-374 to His,
Leu, or Ala completely abolished fusogenicity (Fig. 3). The V410A,
S411P, and Y374A substitutions did not affect MBP-gp21 trimerization (data not shown), and V410A and Y374A MBP-gp21 mutants were recognized by conformational MAbs, HT2 and HT48, raised against MBP-gp21 (H. E. Drummer and P. Poumbourios, unpublished observation). The ability of
these mutants to retain a global helical hairpin conformation despite
the loss of fusion activity may be due to multiple contacts being used
to pack the C-terminal ectodomain segment into the groove on the
surface of the coiled coil (28).
Implications for membrane fusion. Recent models of retrovirus fusion (12, 45) are based on the influenza virus HA2 fusion process, in which endosomal pH induces refolding of the metastable prefusogenic HA2 structure into a thermostable, ~110-Å-long fusion-active helical rod (6, 14). Whereas the receptor for HTLV-1 is not known, studies with HIV-1 (23, 27, 47), simian immunodeficiency virus (SIV) (3), and avian leukosis and sarcoma virus (15, 26) indicate that receptor binding by SU is the fusion activation trigger for retrovirus TM proteins. TM protein fragments derived from MuLV, HIV-1, SIV, Ebola virus, simian virus 5, and influenza virus also adopt thermostable helical hairpin structures analogous to fusion-activated HA2 when expressed in E. coli in the absence of receptor-binding subunits (4, 6, 11, 22, 33, 34, 48, 50, 51). These structures imply that the N-terminal fusion peptide and C-terminal TM sequence are positioned at the same end of the rod, consistent with a structure that closely apposes viral and target cellular membranes in order that they may fuse.
The data presented here indicate that retrovirus Env fusion competence requires that the central coiled coil of the fusion-activated TM protein structure be stabilized by an N-terminal helix cap and C-terminal hydrophobic cluster. These interactions may help to lock the central coiled coil into a stable membrane-embedded rod about which the fusion-inducing conformational change occurs. Our data are also consistent with the idea that the region of chain reversal plays a conserved role in transmitting a conformational signal from receptor-bound SU to the TM protein so that the fusion-activated helical hairpin structure can be induced. A hypothetical pathway for the conformational change is summarized in Fig. 6, using HTLV-1 Env as an example. Receptor binding by SU induces the expulsion of Phe-402 from the core of prefusogenic Env to a solvent-exposed location. Refolding of the TM protein to a more stable conformation involves movement of the disulfide-bonded loop about the Gly-Gly motif to allow formation of the Arg-380-Glu-398 salt bridge.
|
| |
ACKNOWLEDGMENTS |
|---|
We thank Ken Mitchellhill and Kirilee Wilson for mass spectrometry and the NIH AIDS Research and Reference Reagent Program for the supply of vTF7.3, pNL4.3, and MAb C8.
This work was supported by grants from the NHMRC, NIH, and Wellcome Trust. B.K. is a Wellcome Senior Research Fellow in Medical Science in Australia. B.E.K. is an NHMRC Fellow.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: St. Vincent's Institute of Medical Research, 41 Victoria Pde, Fitzroy VIC 3065, Australia. Phone: 61-3-9288-2480. Fax: 61-3-9416-2676. E-mail: apoum{at}ariel.its.unimelb.edu.au.
Present address: Laboratory of Viral Diseases, National Institute
of Allergy and Infectious Diseases, National Institutes of Health,
Bethesda, Md.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abacioglu, Y. H., T. R. Fouts, J. D. Laman, E. Claassen, S. H. Pincus, J. P. Moore, C. A. Roby, R. Kamin-Lewis, and G. K. Lewis. 1994. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res. Hum. Retrovir. 10:371-381[Medline]. |
| 2. |
Adachi, A.,
H. E. Gendelman,
S. Koenig,
T. Folks,
R. Willey,
A. Rabson, and M. A. Martin.
1986.
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
J. Virol.
59:284-291 |
| 3. |
Allan, J. S.,
J. Strauss, and D. W. Buck.
1990.
Enhancement of SIV infection with soluble receptor molecules.
Science
247:1084-1088 |
| 4. | Baker, K. A., R. E. Dutch, R. A. Lamb, and T. S. Jardetzky. 1999. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 3:309-319[CrossRef][Medline]. |
| 5. |
Binley, J. M.,
R. W. Sanders,
B. Clas,
N. Schuelke,
A. Master,
Y. Guo,
F. Kajumo,
D. J. Anselma,
P. J. Maddon,
W. C. Olson, and J. P. Moore.
2000.
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
J. Virol.
74:627-643 |
| 6. | Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43[CrossRef][Medline]. |
| 7. | Caffrey, M., M. Cai, J. Kaufman, S. J. Stahl, P. T. Wingfield, D. G. Covell, A. M. Gronenborn, and G. M. Clore. 1998. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J. 17:4572-4584[CrossRef][Medline]. |
| 8. |
Cao, J.,
L. Bergeron,
E. Helseth,
M. Thali,
H. Repke, and J. Sodroski.
1993.
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
J. Virol.
67:2747-2755 |
| 9. | Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832[CrossRef][Medline]. |
| 10. | Center, R. J., B. Kobe, K. A. Wilson, T. Teh, G. J. Howlett, B. E. Kemp, and P. Poumbourios. 1998. Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein. Protein Sci. 7:1612-1619[Medline]. |
| 11. | Chan, D. C., D. Fass, J. M. Berger, and P. S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273[CrossRef][Medline]. |
| 12. | Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684[CrossRef][Medline]. |
| 13. | Chen, J., K. H. Lee, D. A. Steinhauer, D. J. Stevens, J. J. Skehel, and D. C. Wiley. 1998. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409-417[CrossRef][Medline]. |
| 14. |
Chen, J.,
J. J. Skehel, and D. C. Wiley.
1999.
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA2 subunit to form an N cap that terminates the triple-stranded coiled coil.
Proc. Natl. Acad. Sci. USA
96:8967-8972 |
| 15. |
Damico, R. L.,
J. Crane, and P. Bates.
1998.
Receptor-triggered membrane association of a model retroviral glycoprotein.
Proc. Natl. Acad. Sci. USA
95:2580-2585 |
| 16. |
Dedera, D.,
R. Gu, and L. Ratner.
1992.
Conserved cysteine residues in the human immunodeficiency virus type 1 transmembrane envelope protein are essential for precursor envelope cleavage.
J. Virol.
66:1207-1209 |
| 17. | Doig, A. J., M. W. MacArthur, B. J. Stapley, and J. M. Thornton. 1997. Structures of N-termini of helices in proteins. Protein Sci. 6:147-155[Medline]. |
| 18. | Dubay, J. W., S. R. Dubay, H.-J. Shin, and E. Hunter. 1995. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 69:4675-4682[Abstract]. |
| 19. |
Eriksson, A. E.,
W. A. Baase,
X. J. Zhang,
D. W. Heinz,
M. Blaber,
E. P. Baldwin, and B. W. Matthews.
1992.
Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect.
Science
255:178-183 |
| 20. | Esnouf, R. M. 1997. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15:132-134[CrossRef][Medline]. |
| 21. |
Farzan, M.,
H. Choe,
E. Desjardins,
Y. Sun,
J. Kuhn,
J. Cao,
D. Archambault,
P. Kolchinsky,
M. Koch,
R. Wyatt, and J. Sodroski.
1998.
Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain.
J. Virol.
72:7620-7625 |
| 22. | Fass, D., S. C. Harrison, and P. S. Kim. 1996. Retrovirus envelope domain at 1.7 Å resolution. Nat. Struct. Biol. 3:465-469[CrossRef][Medline]. |
| 23. | Furuta, R. A., C. T. Wild, Y. Weng, and C. D. Weiss. 1998. Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 5:276-279[CrossRef][Medline]. |
| 24. | Greenwood, F. C., W. M. Hunter, and J. S. Glover. 1963. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89:114-123[Medline]. |
| 25. |
Helseth, E.,
U. Olshevsky,
C. Furman, and J. Sodroski.
1991.
Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein.
J. Virol.
65:2119-2123 |
| 26. |
Hernandez, L. D.,
R. J. Peters,
S. E. Delos,
J. A. Young,
D. A. Agard, and J. M. White.
1997.
Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein.
J. Cell Biol.
139:1455-1464 |
| 27. |
Jones, P. L.,
T. Korte, and R. Blumenthal.
1998.
Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors.
J. Biol. Chem.
273:404-409 |
| 28. |
Kobe, B.,
R. J. Center,
B. E. Kemp, and P. Poumbourios.
1999.
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins.
Proc. Natl. Acad. Sci. USA
96:4319-4324 |
| 29. |
Leamnson, R. N., and M. S. Halpern.
1976.
Subunit structure of the glycoprotein complex of avian tumor virus.
J. Virol.
18:956-968 |
| 30. | Lo Conte, L., C. Chothia, and J. Janin. 1999. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285:2177-2198[CrossRef][Medline]. |
| 31. |
Luneberg, J.,
I. Martin,
F. Nussler,
J. M. Ruysschaert, and A. Herrmann.
1995.
Structure and topology of the influenza virus fusion peptide in lipid bilayers.
J. Biol. Chem.
270:27606-27614 |
| 32. | Macosko, J. C., C. H. Kim, and Y. K. Shin. 1997. The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR. J. Mol. Biol. 267:1139-1148[CrossRef][Medline]. |
| 33. |
Malashkevich, V. N.,
D. C. Chan,
C. T. Chutkowski, and P. S. Kim.
1998.
Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.
Proc. Natl. Acad. Sci. USA
95:9134-9139 |
| 34. |
Malashkevich, V. N.,
B. J. Schneider,
M. L. McNally,
M. A. Milhollen,
J. X. Pang, and P. S. Kim.
1999.
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution.
Proc. Natl. Acad. Sci. USA
96:2662-2667 |
| 35. | Merritt, E. A., and D. J. Bacon. 1997. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277:505-525[Medline]. |
| 36. | Moss, B., O. Elroy-Stein, T. Mizukami, W. A. Alexander, and T. R. Fuerst. 1990. New mammalian expression vectors. Nature 348:91-92[CrossRef][Medline]. |
| 37. | Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281-296[CrossRef][Medline]. |
| 38. | Pinter, A., R. Kopelman, Z. Li, S. C. Kayman, and D. A. Sanders. 1997. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes. J. Virol. 71:8073-8077[Abstract]. |
| 39. |
Pique, C.,
D. Pham,
T. Tursz, and M.-C. Dokhélar.
1992.
Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation.
J. Virol.
66:906-913 |
| 40. |
Poumbourios, P.,
K. A. Wilson,
R. J. Center,
W. El Ahmar, and B. E. Kemp.
1997.
Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic -helical/leucine zipper-like sequence.
J. Virol.
71:2041-2049[Abstract].
|
| 41. | Rosenberg, A. R., L. Delamarre, C. Pique, D. Pham, and M.-C. Dokhélar. 1997. The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events. J. Virol. 71:7180-7186[Abstract]. |
| 42. | Rosenthal, P. B., X. Zhang, F. Formanowski, W. Fitz, C. H. Wong, H. Meier-Ewert, J. J. Skehel, and D. C. Wiley. 1998. Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature 396:92-96[CrossRef][Medline]. |
| 43. |
Salzwedel, K.,
J. T. West, and E. Hunter.
1999.
A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.
J. Virol.
73:2469-2480 |
| 44. |
Sanchez, A.,
Z.-Y. Yang,
L. Xu,
G. J. Nabel,
T. Crews, and C. J. Peters.
1998.
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus.
J. Virol.
72:6442-6447 |
| 45. | Skehel, J. J., and D. C. Wiley. 1998. Coiled coils in both intracellular vesicle and viral membrane fusion. Cell 95:871-874[CrossRef][Medline]. |
| 46. | Stites, W. E., and J. Pranata. 1995. Empirical evaluation of the influence of side chains on the conformational entropy of the polypeptide backbone. Proteins 22:132-140[CrossRef][Medline]. |
| 47. | Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422[Abstract]. |
| 48. |
Tan, K.,
J. Liu,
J. Wang,
S. Shen, and M. Lu.
1997.
Atomic structure of a thermostable subdomain of HIV-1 gp41.
Proc. Natl. Acad. Sci. USA
94:12303-12308 |
| 49. | Thomas, A., and M. J. Roth. 1995. Analysis of cysteine mutations on the transmembrane protein of Moloney murine leukemia virus. Virology 211:285-289[CrossRef]. |
| 50. | Weissenhorn, W., A. Carfi, K. H. Lee, J. J. Skehel, and D. C. Wiley. 1998. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell 2:605-616[CrossRef][Medline]. |
| 51. | Weissenhorn, W., A. Dessen, S. C. Harrison, J. J. Skehel, and D. C. Wiley. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387:426-430[CrossRef][Medline]. |
| 52. | Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366-373[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»